Julie Clark - Sep 30, 2021 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Medical Officer
Signature
Julie Clark, by /s/ Ron A. Metzger, Attorney-in-Fact.
Stock symbol
ADVM
Transactions as of
Sep 30, 2021
Transactions value $
-$10,342
Form type
4
Date filed
10/4/2021, 05:36 PM
Previous filing
Aug 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Sale -$10.3K -4.77K -2.81% $2.17 165K Sep 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees.